REMINDER: Ultra Petroleum Corp. to Webcast Third Quarter 2017 Results
Nov 07, 2017 12:45 pm UTC| Business
Houston, TX, Nov. 07, 2017 -- Ultra Petroleum Corp. (NASDAQ: UPL) announces the following Webcast to discuss its third quarter 2017 financial and operating results: What: Ultra Petroleum Corp. Third Quarter...
Drug Delivery in Cancer Markets, 2016-2026 Analysis Report
Nov 07, 2017 12:41 pm UTC| Business
Dublin, Nov. 07, 2017 -- The "Drug Delivery in Cancer - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering. Drug delivery remains a...
Nov 07, 2017 12:40 pm UTC| Business
NEW YORK, Nov. 07, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Philip Morris...
World Personalized Medicine Scientific and Commercial Report 2017
Nov 07, 2017 12:37 pm UTC| Business
Dublin, Nov. 07, 2017 -- The "Personalized Medicine - Scientific and Commercial Aspects" report from Jain PharmaBiotech has been added to Research and Markets' offering. The aim of personalized...
Global Nitric Oxide Therapeutics, Markets and Companies Report 2017 - Projections to 2021 & 2026
Nov 07, 2017 12:34 pm UTC| Business
Dublin, Nov. 07, 2017 -- The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering. This report describes the latest...
Affimed Reports Financial Results for Third Quarter 2017
Nov 07, 2017 12:31 pm UTC| Business
Heidelberg, Germany, November 7, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported financial results...
Spark Therapeutics Reports Third Quarter 2017 Financial Results and Recent Business Progress
Nov 07, 2017 12:31 pm UTC| Business
PHILADELPHIA, Pa., Nov. 07, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today financial results for the...